Free Newsletter
New stem cell therapy targets muscular dystrophy
In what's being described as a breakthrough research project, stem cells were used to treat the symptoms of muscular dystrophy in dogs. Giulio Cossu, director of the stem cell institute at the San Raffaele Scientific Institute in Milan, Italy, led the international team of researchers, whose work was published in the online edition of Nature. Taking stem cells from the blood vessel walls of the dogs--an approach similar to using adult stem cells--the researchers repeatedly injected them into the blood stream of dogs suffering from an ailment very similar to Duchenne muscular dystrophy, which afflicts one in every 3,500 newly born male children. Cossu says that his research indicates that genetically manipulating an individual's own stem cells may be the best approach to finding a way to use stem cells as a cure.
- read the AP report on the research project
Related Articles:
Researchers find on-off "switch" for muscular dystrophy. Report
Increased versatility found in adult stem cell. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: